• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

赖诺普利的性别相关药代动力学和药效学差异。

Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril.

作者信息

Sáenz-Campos D, Bayés M C, Masana E, Martín S, Barbanoj M, Jané F

机构信息

Department of Pharmacology and Clinical Toxicology, Faculty of Medicine, University of Costa Rica.

出版信息

Methods Find Exp Clin Pharmacol. 1996 Oct;18(8):533-8.

PMID:9044242
Abstract

The aim of the present study was to determine whether or not the pharmacokinetic and hemodynamic response to a 20 mg single oral dose of lisinopril was sex-dependent. Thirty-two young healthy volunteers (16 males and 16 females) were included in the trial. Blood samples to assess lisinopril plasma concentrations, determined indirectly by inhibition of the angiotensin converting enzyme (ACE) and hemodynamic variables, were obtained before and at different times following drug intake. No significant differences in pharmacokinetic parameters were observed between males and females. An hypotensive response was obtained between 2 and 10 h for systolic blood pressure and between 2 and 24 h for diastolic blood pressure. Again, no significant sex-related differences were noted. Lisinopril was well tolerated.

摘要

本研究的目的是确定单次口服20毫克赖诺普利后的药代动力学和血流动力学反应是否存在性别差异。32名年轻健康志愿者(16名男性和16名女性)参与了该试验。在服药前及服药后的不同时间采集血样,以评估赖诺普利的血浆浓度(通过抑制血管紧张素转换酶(ACE)间接测定)和血流动力学变量。男性和女性之间未观察到药代动力学参数的显著差异。收缩压在服药后2至10小时出现降压反应,舒张压在服药后2至24小时出现降压反应。同样,未发现显著的性别相关差异。赖诺普利耐受性良好。

相似文献

1
Sex-related pharmacokinetic and pharmacodynamic variations of lisinopril.赖诺普利的性别相关药代动力学和药效学差异。
Methods Find Exp Clin Pharmacol. 1996 Oct;18(8):533-8.
2
Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.在5/6肾切除大鼠中,对血管紧张素转换酶(ACE)抑制的治疗抵抗与药效学和药代动力学因素有关。
Eur J Pharmacol. 2008 Feb 2;580(1-2):231-40. doi: 10.1016/j.ejphar.2007.10.060. Epub 2007 Oct 30.
3
Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.在原发性高血压中,sampatrilat对中性内肽酶和血管紧张素转换酶的联合抑制作用
Clin Pharmacol Ther. 1998 Oct;64(4):439-49. doi: 10.1016/S0009-9236(98)90075-3.
4
Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol.赖诺普利和依那普利单独使用及与普萘洛尔联合使用时的比较药代动力学和药效学
J Hum Hypertens. 1989 Jun;3 Suppl 1:139-45.
5
No sex-related pharmacokinetic and pharmacodynamic differences of captopril.卡托普利不存在与性别相关的药代动力学和药效学差异。
Pharmacol Res. 1997 Jul;36(1):41-7. doi: 10.1006/phrs.1997.0202.
6
Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.依那普利和赖诺普利在肝功能正常和受损受试者中的药代动力学。
J Hum Hypertens. 1989 Jun;3 Suppl 1:153-8.
7
Lisinopril for the treatment of hypertension within the first 24 hours of acute ischemic stroke and follow-up.赖诺普利用于急性缺血性卒中发病后24小时内高血压的治疗及随访。
Am J Hypertens. 2007 Mar;20(3):270-7. doi: 10.1016/j.amjhyper.2006.08.005.
8
Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.赖诺普利与拉西地平对II型糖尿病肾病患者尿白蛋白排泄的比较效果。
Afr J Med Med Sci. 2002 Mar;31(1):53-7.
9
ACE inhibition and protection from doxorubicin-induced cardiotoxicity in the rat.血管紧张素转换酶抑制与大鼠多柔比星诱导的心脏毒性的防护作用
Vascul Pharmacol. 2009 May-Jun;50(5-6):166-70. doi: 10.1016/j.vph.2009.01.001.
10
Bioequivalence evaluation of two brands of lisinopril tablets (Lisotec and Zestril) in healthy human volunteers.
Biopharm Drug Dispos. 2005 Nov;26(8):335-9. doi: 10.1002/bdd.465.

引用本文的文献

1
Achieved dose and treatment discontinuation of candesartan in men and women with chronic heart failure: data from CHARM.坎地沙坦在慢性心力衰竭男性和女性患者中的剂量和停药情况:来自 CHARM 的数据。
ESC Heart Fail. 2024 Aug;11(4):1880-1887. doi: 10.1002/ehf2.14715. Epub 2024 Apr 5.
2
Sex differences in stroke co-morbidities.脑卒中合并症的性别差异。
Exp Neurol. 2020 Oct;332:113384. doi: 10.1016/j.expneurol.2020.113384. Epub 2020 Jun 23.
3
New and emerging prophylactic agents for migraine.新型和正在出现的偏头痛预防药物。
CNS Drugs. 2002;16(9):611-34. doi: 10.2165/00023210-200216090-00003.